https://news.medxy.ai/zh/81153-2/Medxy AIzh2026-10-03T10:08:11-07:00 https://news.medxy.ai/ja/naion-optic-nerve-swelling/Medxy AIja2026-10-03T10:07:48-07:00NAIONの視機能悪化を左右する早期視神経乳頭腫脹速度：エビデンスに基づく総説 https://news.medxy.ai/vi/optic-nerve-conduction-speed/Medxy AIvi2026-10-03T10:07:22-07:00Tốc độ phù đầu dây thần kinh thị giác sớm liên quan với suy giảm thị lực trong bệnh lý thần kinh thị giác thiếu máu cục bộ trước không do động mạch: Tổng quan dựa trên bằng chứng https://news.medxy.ai/zh/pertussis-antibiotic-evidence/Medxy AIzh2026-10-03T08:08:51-07:00百日咳婴儿抗菌治疗新证据：意大利医院真实世界研究显示克拉霉素优于阿奇霉素 https://news.medxy.ai/ja/79982-2/Medxy AIja2026-10-03T08:08:33-07:00百日咳の乳児において、クラリスロマイシンはアジスロマイシンより優れている https://news.medxy.ai/vi/79978-2/Medxy AIvi2026-10-03T08:08:09-07:00Các nghiên cứu thực tế cho thấy clarithromycin vượt trội hơn azithromycin ở trẻ nhũ nhi mắc bệnh ho gà https://news.medxy.ai/clarithromycin-vs-azithromycin-for-infant-pertussis-real-world-outcomes-from-italian-hospitals/Medxy AIen2026-10-03T08:07:49-07:00Clarithromycin vs Azithromycin for Infant Pertussis: Real-World Outcomes from Italian Hospitals https://news.medxy.ai/zh/pcv-vaccine-followup/Medxy AIzh2026-10-03T08:07:04-07:00南非肺炎球菌结合疫苗加强免疫后最长追踪至5岁：PCV10与PCV13婴儿1+1及2+1程序的随机对照试验延长随访 https://news.medxy.ai/ja/pneumococcal-vaccine-study/Medxy AIja2026-10-03T08:06:39-07:00南アフリカにおける10価・13価肺炎球菌結合型ワクチンの乳児初回接種後、5歳までの免疫原性：ブースター追加を伴う延長RCT追跡 https://news.medxy.ai/vi/pcv13-immunity-children/Medxy AIvi2026-10-03T08:06:16-07:00Miễn dịch của PCV13 kéo dài đến 5 tuổi sau lịch tiêm 1 hoặc 2 liều khởi đầu ở trẻ nhỏ kèm liều nhắc tại Nam Phi: theo dõi mở rộng của thử nghiệm ngẫu nhiên có đối chứng https://news.medxy.ai/immunogenicity-up-to-age-5-following-single-or-two-dose-infant-primary-series-of-10-valent-and-13-valent-pneumococcal-conjugate-vaccine-with-booster-in-south-africa-extended-rct-follow-up/Medxy AIen2026-10-03T08:05:54-07:00Immunogenicity up to Age 5 Following Single- or Two-Dose Infant Primary Series of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccine with Booster in South Africa: Extended RCT Follow-Up https://news.medxy.ai/health-service-utilization-among-young-people-following-out-of-area-mental-health-admissions-evidence-from-a-retrospective-cohort-study-in-england/Medxy AIen2026-10-03T08:00:12-07:00Health Service Utilization Among Young People Following Out-of-Area Mental Health Admissions: Evidence from a Retrospective Cohort Study in England https://news.medxy.ai/zh/extremely-preterm-birth/Medxy AIzh2026-10-03T07:59:21-07:00超早产与极低出生体重人群成年福祉的儿童期预测因素：一项34年队列研究的启示 https://news.medxy.ai/ja/early-birth-wellbeing/Medxy AIja2026-10-03T07:59:03-07:00超早産・超低出生体重で生まれた人の成人ウェルビーイングを左右する小児期予測因子：34年コホート研究からの知見 https://news.medxy.ai/vi/childhood-predictors-health/Medxy AIvi2026-10-03T07:58:41-07:00Những yếu tố dự báo từ thời thơ ấu đối với sức khỏe và thích nghi tốt ở tuổi trưởng thành ở người sinh cực non và/hoặc có cân nặng lúc sinh rất thấp: phát hiện từ nghiên cứu đoàn hệ 34 năm https://news.medxy.ai/childhood-predictors-of-adult-well-being-in-very-preterm-and-very-low-birth-weight-individuals-insights-from-a-34-year-cohort-study/Medxy AIen2026-10-03T07:58:19-07:00Childhood Predictors of Adult Well-Being in Very Preterm and Very Low Birth Weight Individuals: Insights From a 34-Year Cohort Study https://news.medxy.ai/zh/rsv-infant-protection/Medxy AIzh2026-10-02T07:57:33-07:00高风险婴儿重症 RSV 的长效防护：两季随机试验揭示克雷索维单抗潜力 https://news.medxy.ai/ja/high-risk-infant-rsv-prevention/Medxy AIja2026-10-02T07:57:12-07:00高リスク乳児の重症RSVを長期に防ぐclesrovimab：2シーズン無作為化試験からの知見 https://news.medxy.ai/vi/clesrovimab-rsv-prevention-4/Medxy AIvi2026-10-02T07:56:49-07:00Clesrovimab: hy vọng mới trong phòng ngừa RSV nặng kéo dài ở trẻ sơ sinh nguy cơ cao https://news.medxy.ai/clesrovimab-for-prolonged-protection-against-severe-rsv-in-high-risk-infants-insights-from-a-two-season-randomized-trial/Medxy AIen2026-10-02T07:56:29-07:00Clesrovimab for Prolonged Protection Against Severe RSV in High-Risk Infants: Insights From a Two-Season Randomized Trial https://news.medxy.ai/zh/38-percent-silver-ammonium-fluoride/Medxy AIzh2026-10-02T07:55:46-07:0038%银氨氟化物：重度幼儿期龋的非侵入性治疗新突破 https://news.medxy.ai/ja/silver-diamine-fluoride/Medxy AIja2026-10-02T07:55:26-07:0038％silver diamine fluorideが切り開く新たな小児う蝕治療――米国の重度幼児う蝕に対する非侵襲的ブレークスルー https://news.medxy.ai/vi/silver-diamine-fluoride-2/Medxy AIvi2026-10-02T07:55:01-07:00Bạc diamine fluoride: Liệu pháp không xâm lấn đột phá cho sâu răng sớm ở trẻ em nặng tại Hoa Kỳ https://news.medxy.ai/silver-diamine-fluoride-a-breakthrough-noninvasive-therapy-for-severe-early-childhood-caries-in-us-children/Medxy AIen2026-10-02T07:54:37-07:00Silver Diamine Fluoride: A Breakthrough Noninvasive Therapy for Severe Early Childhood Caries in US Children https://news.medxy.ai/zh/pediatric-tbi-ct-use/Medxy AIzh2026-10-02T07:53:59-07:00儿童轻型创伤性脑损伤头部CT使用率居高不下：不同医院类型差异及其对临床实践的启示 https://news.medxy.ai/ja/79927-2/Medxy AIja2026-10-02T07:53:38-07:00小児の軽症外傷性脳損傷における頭部CT撮影率の高止まり https://news.medxy.ai/vi/79926-2/Medxy AIvi2026-10-02T07:53:11-07:00Tỷ lệ sử dụng chụp CT đối với chấn thương sọ não nhẹ ở trẻ em vẫn duy trì ở mức cao https://news.medxy.ai/persistent-high-rates-of-head-ct-in-pediatric-mild-traumatic-brain-injury-variability-among-hospital-types-and-implications-for-practice/Medxy AIen2026-10-02T07:52:48-07:00Persistent High Rates of Head CT in Pediatric Mild Traumatic Brain Injury: Variability Among Hospital Types and Implications for Practice https://news.medxy.ai/zh/type-1-diabetes-intervention/Medxy AIzh2026-10-02T07:52:05-07:00儿童1型糖尿病的行为干预：以家庭为中心的多组分策略优化血糖控制 https://news.medxy.ai/ja/pediatric-type1-diabetes/Medxy AIja2026-10-02T07:51:42-07:00小児1型糖尿病における行動介入：家族中心の多要素戦略で血糖管理を最適化する https://news.medxy.ai/vi/behavioral-intervention-type-1-diabetes/Medxy AIvi2026-10-02T07:51:19-07:00Can thiệp hành vi trong đái tháo đường type 1 ở trẻ em: tối ưu kiểm soát đường huyết bằng chiến lược đa thành phần, lấy gia đình làm trung tâm https://news.medxy.ai/behavioral-interventions-in-pediatric-type-1-diabetes-optimizing-glycemic-control-through-family-centered-multicomponent-strategies/Medxy AIen2026-10-02T07:50:54-07:00Behavioral Interventions in Pediatric Type 1 Diabetes: Optimizing Glycemic Control Through Family-Centered, Multicomponent Strategies https://news.medxy.ai/zh/79910-2/Medxy AIzh2026-10-02T07:50:10-07:00加强对拉美裔家庭婴幼儿读写能力的支持：一项验证短信与社区资源推介有效性的三组随机对照试验（RCT） https://news.medxy.ai/ja/latin-family-literacy/Medxy AIja2026-10-02T07:49:49-07:00ラテン系家族の乳幼児リテラシー支援を強化：テキストメッセージと地域資源紹介の有効性を検証した3群RCT https://news.medxy.ai/vi/promoting-childrens-reading/Medxy AIvi2026-10-02T07:49:20-07:00Tăng cường thúc đẩy đọc sách cho trẻ em trong các gia đình Latino: hiệu quả của nhắn tin văn bản và giới thiệu nguồn lực trong thử nghiệm ngẫu nhiên có đối chứng 3 nhánh https://news.medxy.ai/enhancing-pediatric-literacy-promotion-for-latino-families-efficacy-of-text-messaging-and-resource-referrals-in-a-3-arm-randomized-controlled-trial/Medxy AIen2026-10-02T07:48:55-07:00Enhancing Pediatric Literacy Promotion for Latino Families: Efficacy of Text Messaging and Resource Referrals in a 3-Arm Randomized Controlled Trial https://news.medxy.ai/zh/mri-ultrasound-arthritis/Medxy AIzh2026-10-02T07:48:06-07:00MRI 与超声可预测 anti-CCP 阳性无临床滑膜炎患者进展为炎性关节炎 https://news.medxy.ai/ja/inflammatory-arthritis-risk/Medxy AIja2026-10-02T07:47:42-07:00MRIと超音波で見抜く炎症性関節炎リスク：anti-CCP陽性・無症候性滑膜炎患者の予測因子 https://news.medxy.ai/vi/anti-ccp-arthritis-markers/Medxy AIvi2026-10-02T07:47:19-07:00Dấu ấn hình ảnh nào dự báo viêm khớp viêm ở người anti-CCP dương tính chưa có viêm hoạt dịch lâm sàng? https://news.medxy.ai/imaging-biomarkers-predicting-inflammatory-arthritis-in-anti-ccp-positive-patients-without-clinical-synovitis/Medxy AIen2026-10-02T07:46:56-07:00Imaging Biomarkers Predicting Inflammatory Arthritis in Anti-CCP Positive Patients Without Clinical Synovitis https://news.medxy.ai/zh/anca-vasculitis-relapse-risk/Medxy AIzh2026-10-02T07:46:16-07:00预测ANCA相关性血管炎两年复发风险：来自 PEXIVAS 试验的启示 https://news.medxy.ai/ja/anca-vasculitis-relapse-risk-3/Medxy AIja2026-10-02T07:45:54-07:00ANCA関連血管炎の2年再燃リスクを予測：PEXIVAS試験から見えた知見 https://news.medxy.ai/vi/anca-vasculitis-relapse-risk-2/Medxy AIvi2026-10-02T07:45:26-07:00Dự đoán nguy cơ tái phát trong 2 năm ở viêm mạch liên quan đến ANCA: Gợi ý từ thử nghiệm PEXIVAS https://news.medxy.ai/predicting-two-year-relapse-risk-in-anca-associated-vasculitis-insights-from-the-pexivas-trial/Medxy AIen2026-10-02T07:45:03-07:00Predicting Two-Year Relapse Risk in ANCA-Associated Vasculitis: Insights from the PEXIVAS Trial https://news.medxy.ai/zh/canakinumab-biomarkers/Medxy AIzh2026-10-02T07:44:24-07:00预测 canakinumab 减量成功的分子标志物：系统性幼年特发性关节炎的新线索 https://news.medxy.ai/ja/79884-2/Medxy AIja2026-10-02T07:44:03-07:00カナキヌマブ減量成功を予測する分子バイオマーカー https://news.medxy.ai/vi/canakinumab-dose-reduction/Medxy AIvi2026-10-02T07:43:39-07:00Các dấu ấn phân tử dự đoán khả năng giảm liều canakinumab thành công trong viêm khớp tự phát thiếu niên thể hệ thống https://news.medxy.ai/molecular-biomarkers-predicting-canakinumab-tapering-success-in-systemic-juvenile-idiopathic-arthritis/Medxy AIen2026-10-02T07:43:16-07:00Molecular Biomarkers Predicting Canakinumab Tapering Success in Systemic Juvenile Idiopathic Arthritis https://news.medxy.ai/zh/native-vs-transplant-bk-virus/Medxy AIzh2026-10-02T07:42:36-07:00原生肾与移植肾BK多瘤病毒肾病的比较：一项匹配队列研究中的临床与病理洞见 https://news.medxy.ai/ja/bk-polyomavirus-nephropathy/Medxy AIja2026-10-02T07:42:13-07:00自己腎と移植腎のBKポリオーマウイルス腎症を比較する：マッチドコホート研究からみた臨床・病理学的考察 https://news.medxy.ai/vi/79878-2/Medxy AIvi2026-10-02T07:41:49-07:00So sánh bệnh thận do virus BK Polyoma ở thận tự thân và thận ghép https://news.medxy.ai/comparative-insights-into-native-and-allograft-bk-polyomavirus-nephropathy-clinical-and-pathological-perspectives-from-a-matched-cohort-study/Medxy AIen2026-10-02T07:41:25-07:00Comparative Insights into Native and Allograft BK Polyomavirus Nephropathy: Clinical and Pathological Perspectives from a Matched Cohort Study https://news.medxy.ai/zh/optimize-kidney-transplant/Medxy AIzh2026-10-02T07:40:36-07:00优化肾移植结局：来自全国性双肾与单肾移植比较研究的启示 https://news.medxy.ai/ja/79866-2/Medxy AIja2026-10-02T07:40:14-07:00腎移植成績の最適化：両腎移植と単腎移植を比較した全国規模の研究からの示唆 https://news.medxy.ai/vi/kidney-transplant-optimization/Medxy AIvi2026-10-02T07:39:38-07:00Tối ưu hóa kết quả ghép thận: Góc nhìn từ một nghiên cứu quốc gia về ghép thận đôi so với ghép thận đơn https://news.medxy.ai/optimizing-kidney-transplant-outcomes-insights-from-a-national-study-on-dual-versus-single-kidney-transplantation/Medxy AIen2026-10-02T07:39:15-07:00Optimizing Kidney Transplant Outcomes: Insights from a National Study on Dual Versus Single Kidney Transplantation https://news.medxy.ai/zh/spain-organ-donation-trends/Medxy AIzh2026-10-02T07:38:23-07:00西班牙脑死亡器官捐献格局如何变化：神经重症医学与器官捐献趋势的全国概览 https://news.medxy.ai/ja/brain-death-organ-donation-spain/Medxy AIja2026-10-02T07:38:01-07:00スペインにおける脳死下臓器提供の変化：神経集中治療と臓器提供動向の全国的概観 https://news.medxy.ai/vi/spain-organ-donation/Medxy AIvi2026-10-02T07:37:36-07:00Tây Ban Nha trước sự dịch chuyển của hiến tạng sau chết não: Tổng quan quốc gia về hồi sức thần kinh và xu hướng hiến tạng https://news.medxy.ai/changing-brain-death-donation-dynamics-in-spain-a-national-overview-of-neurocritical-care-and-organ-donation-trends/Medxy AIen2026-10-02T07:37:14-07:00Changing Brain Death Donation Dynamics in Spain: A National Overview of Neurocritical Care and Organ Donation Trends https://news.medxy.ai/zh/medicaid-liver-transplant/Medxy AIzh2026-10-02T07:36:25-07:00Medicaid 扩大覆盖如何改善成人肝移植结局：长达十年的研究分析 https://news.medxy.ai/ja/medicaid-liver-transplant-2/Medxy AIja2026-10-02T07:36:08-07:00Medicaid拡大が成人肝移植転帰に与える影響：10年間の解析 https://news.medxy.ai/vi/medicaid-expansion-liver-transplant/Medxy AIvi2026-10-02T07:35:49-07:00Mở rộng Medicaid tác động thế nào đến kết cục ghép gan ở người lớn? Phân tích kéo dài 10 năm https://news.medxy.ai/impact-of-medicaid-expansion-on-adult-liver-transplant-outcomes-a-decade-long-analysis/Medxy AIen2026-10-02T07:35:29-07:00Impact of Medicaid Expansion on Adult Liver Transplant Outcomes: A Decade-Long Analysis https://news.medxy.ai/zh/lung-function-transplant/Medxy AIzh2026-10-02T07:34:43-07:00肝移植受者肺功能受损与呼吸困难：全国匹配队列研究带来的启示 https://news.medxy.ai/ja/lung-function-decline/Medxy AIja2026-10-02T07:34:23-07:00肝移植レシピエントにおける肺機能低下と呼吸困難：全国マッチドコホート研究からの示唆 https://news.medxy.ai/vi/lung-function-decline-2/Medxy AIvi2026-10-02T07:34:03-07:00Suy giảm chức năng phổi và khó thở ở người nhận ghép gan: bằng chứng từ một nghiên cứu đoàn hệ ghép cặp toàn quốc https://news.medxy.ai/impaired-pulmonary-function-and-dyspnea-in-liver-transplant-recipients-insights-from-a-nationwide-matched-cohort-study/Medxy AIen2026-10-02T07:33:43-07:00Impaired Pulmonary Function and Dyspnea in Liver Transplant Recipients: Insights from a Nationwide Matched Cohort Study https://news.medxy.ai/zh/liver-transplantation-advances/Medxy AIzh2026-10-02T07:32:59-07:00循环死亡后捐献肝移植新进展：常温机器灌注与区域灌注结局比较 https://news.medxy.ai/ja/liver-transplantation-comparison/Medxy AIja2026-10-02T07:32:35-07:00循環停止後臓器提供肝移植を前進させる：常温機械灌流と区域灌流の成績比較 https://news.medxy.ai/vi/liver-transplantation-comparison-2/Medxy AIvi2026-10-02T07:32:11-07:00Nâng tầm ghép gan từ người hiến sau ngừng tuần hoàn: so sánh kết cục tưới máu máy ở thân nhiệt bình thường và tưới máu vùng https://news.medxy.ai/advancing-donation-after-circulatory-death-liver-transplants-comparing-normothermic-machine-and-regional-perfusion-outcomes/Medxy AIen2026-10-02T07:31:48-07:00Advancing Donation After Circulatory Death Liver Transplants: Comparing Normothermic Machine and Regional Perfusion Outcomes https://news.medxy.ai/zh/dupilumab-eczema-kids/Medxy AIzh2026-10-02T07:31:04-07:00dupilumab治疗儿童中重度特应性皮炎：荷兰3年队列研究揭示长期疗效与安全性 https://news.medxy.ai/ja/dupilumab-child-eczema/Medxy AIja2026-10-02T07:30:42-07:00中等症から重症の小児アトピー性皮膚炎におけるDupilumabの長期有効性と安全性：オランダ3年間コホート研究からの知見 https://news.medxy.ai/vi/dupilumab-long-term-safety/Medxy AIvi2026-10-02T07:30:15-07:00Dupilumab duy trì hiệu quả và độ an toàn lâu dài ở trẻ em mắc viêm da cơ địa mức độ trung bình đến nặng: Kết quả từ nghiên cứu đoàn hệ 3 năm tại Hà Lan https://news.medxy.ai/sustained-efficacy-and-safety-of-dupilumab-in-children-with-moderate-to-severe-atopic-dermatitis-insights-from-a-3-year-dutch-cohort-study/Medxy AIen2026-10-02T07:29:55-07:00Sustained Efficacy and Safety of Dupilumab in Children with Moderate to Severe Atopic Dermatitis: Insights from a 3-Year Dutch Cohort Study https://news.medxy.ai/zh/arotitinib-cream-study/Medxy AIzh2026-10-02T07:29:01-07:001.5%芦可替尼乳膏治疗皮肤型扁平苔藓的疗效与安全性：随机临床试验综述 https://news.medxy.ai/ja/lansopitinib-skin-trial/Medxy AIja2026-10-02T07:28:41-07:00皮膚扁平苔癬に対するランソリチニブ外用クリームの有効性と安全性：ランダム化臨床試験レビュー https://news.medxy.ai/vi/ruxolitinib-cream-lichen-planus/Medxy AIvi2026-10-02T07:28:18-07:00Ruxolitinib cream trong lichen phẳng da: Hiệu quả, độ an toàn và ý nghĩa từ một thử nghiệm lâm sàng ngẫu nhiên https://news.medxy.ai/efficacy-and-safety-of-ruxolitinib-cream-in-patients-with-cutaneous-lichen-planus-a-randomized-clinical-trial-review/Medxy AIen2026-10-02T07:27:57-07:00Efficacy and Safety of Ruxolitinib Cream in Patients With Cutaneous Lichen Planus: A Randomized Clinical Trial Review https://news.medxy.ai/high-dose-oral-vitamin-d-for-management-of-chemotherapy-and-radiation-induced-skin-toxicity-a-multicenter-case-series/Medxy AIen2026-10-02T07:27:10-07:00High-Dose Oral Vitamin D for Management of Chemotherapy- and Radiation-Induced Skin Toxicity: A Multicenter Case Series https://news.medxy.ai/zh/rituximab-pemphigus-prediction/Medxy AIzh2026-10-02T07:26:27-07:00利妥昔单抗联合糖皮质激素治疗天疱疮患者短期结局的预测：来自中国多中心队列的启示 https://news.medxy.ai/ja/pemphigus-treatment-prediction/Medxy AIja2026-10-02T07:26:06-07:00リツキシマブ＋グルココルチコイド治療中の天疱瘡患者における短期転帰予測：中国多施設コホートからの知見 https://news.medxy.ai/vi/79791-2/Medxy AIvi2026-10-02T07:25:44-07:00Kết quả ngắn hạn của việc phối hợp rituximab và glucocorticoid ở bệnh nhân mắc bệnh pemphigus https://news.medxy.ai/predicting-short-term-outcomes-in-pemphigus-patients-treated-with-rituximab-and-glucocorticoids-insights-from-a-multicenter-chinese-cohort/Medxy AIen2026-10-02T07:25:26-07:00Predicting Short-Term Outcomes in Pemphigus Patients Treated with Rituximab and Glucocorticoids: Insights from a Multicenter Chinese Cohort https://news.medxy.ai/zh/dupilumab-atopic-dermatitis/Medxy AIzh2026-10-02T07:24:45-07:00儿童中重度特应性皮炎系统治疗新证据：PEDISTAD 登记研究显示 dupilumab 跨肤色疗效更佳 https://news.medxy.ai/ja/atopic-dermatitis-treatment/Medxy AIja2026-10-02T07:24:24-07:00PEDISTADレジストリが示した小児中等症から重症アトピー性皮膚炎に対する全身治療：皮膚色別の比較成績 https://news.medxy.ai/vi/atopic-dermatitis-treatment-2/Medxy AIvi2026-10-02T07:24:01-07:00Điều trị toàn thân viêm da cơ địa mức độ vừa đến nặng ở trẻ em: so sánh kết quả theo màu da từ cơ sở đăng ký PEDISTAD https://news.medxy.ai/systemic-therapies-for-pediatric-moderate-to-severe-atopic-dermatitis-comparative-outcomes-across-skin-colors-from-the-pedistad-registry/Medxy AIen2026-10-02T07:23:40-07:00Systemic Therapies for Pediatric Moderate-to-Severe Atopic Dermatitis: Comparative Outcomes Across Skin Colors from the PEDISTAD Registry https://news.medxy.ai/zh/plaque-psoriasis-flare/Medxy AIzh2026-10-02T07:22:58-07:00停用生物制剂后斑块型银屑病出现独特脓疱性发作：临床特征与危险因素 https://news.medxy.ai/ja/psoriasis-flare-after-treatment/Medxy AIja2026-10-02T07:22:38-07:00生物学的製剤中止後にみられる尋常性乾癬の特異的膿疱性増悪：臨床像と危険因子 https://news.medxy.ai/vi/psoriasis-pustular-flare/Medxy AIvi2026-10-02T07:22:16-07:00Bùng phát vảy nến mụn mủ đặc thù sau khi ngừng thuốc sinh học ở vảy nến mảng bám: đặc điểm lâm sàng và yếu tố nguy cơ https://news.medxy.ai/distinct-pustular-psoriasis-flares-after-biologic-withdrawal-in-plaque-psoriasis-clinical-features-and-risk-factors/Medxy AIen2026-10-02T07:21:53-07:00Distinct Pustular Psoriasis Flares After Biologic Withdrawal in Plaque Psoriasis: Clinical Features and Risk Factors https://news.medxy.ai/zh/breast-reconstruction-outcomes-2/Medxy AIzh2026-10-02T07:21:11-07:00两期乳房重建中聚二氧环己酮合成网片的短期结局：单中心比较研究的启示 https://news.medxy.ai/ja/polydioxanone-mesh-results/Medxy AIja2026-10-02T07:20:52-07:002期的乳房再建におけるポリジオキサノン合成メッシュの短期成績：単施設比較研究からの知見 https://news.medxy.ai/vi/polydioxanone-breast-reconstruction/Medxy AIvi2026-10-02T07:20:30-07:00Kết quả ngắn hạn của lưới tổng hợp polydioxanone trong tái tạo vú hai giai đoạn: Bằng chứng từ một nghiên cứu so sánh đơn trung tâm https://news.medxy.ai/short-term-outcomes-of-polydioxanone-synthetic-mesh-in-two-stage-breast-reconstruction-insights-from-a-single-center-comparative-study/Medxy AIen2026-10-02T07:20:12-07:00Short-Term Outcomes of Polydioxanone Synthetic Mesh in Two-Stage Breast Reconstruction: Insights from a Single-Center Comparative Study https://news.medxy.ai/zh/five-factor-weakness-index/Medxy AIzh2026-10-02T07:19:34-07:00五因素改良衰弱指数能否预测乳房缩小成形术后伤口愈合并发症？高龄或许更关键 https://news.medxy.ai/ja/breast-reduction-healing/Medxy AIja2026-10-02T07:19:11-07:00乳房縮小術後の創傷治癒合併症は予測できるか――5因子修正版フレイル指標の実力を検証 https://news.medxy.ai/vi/79748-2/Medxy AIvi2026-10-02T07:18:47-07:00Liệu có thể dự đoán các biến chứng lành vết thương sau phẫu thuật thu nhỏ vú? https://news.medxy.ai/assessing-the-predictive-value-of-the-5-factor-modified-frailty-index-for-wound-healing-complications-in-reduction-mammoplasty/Medxy AIen2026-10-02T07:18:25-07:00Assessing the Predictive Value of the 5-Factor Modified Frailty Index for Wound-Healing Complications in Reduction Mammoplasty https://news.medxy.ai/zh/adm-reconstruction-timing/Medxy AIzh2026-10-02T07:17:44-07:00前胸壁两期乳房重建中ADM植入时机如何优化：在包膜挛缩与并发症之间寻找平衡 https://news.medxy.ai/ja/adm-timing-optimization/Medxy AIja2026-10-02T07:17:25-07:00前胸壁2段階乳房再建におけるADM留置時期の最適化：被膜拘縮と合併症の両立 https://news.medxy.ai/vi/optimal-adm-timing/Medxy AIvi2026-10-02T07:17:05-07:00Tối ưu thời điểm đặt Acellular Dermal Matrix trong tái tạo vú trước cơ hai thì: Cân bằng giữa co thắt bao xơ và biến chứng https://news.medxy.ai/optimizing-acellular-dermal-matrix-timing-in-2-stage-prepectoral-breast-reconstruction-balancing-capsular-contracture-and-complications/Medxy AIen2026-10-02T07:16:43-07:00Optimizing Acellular Dermal Matrix Timing in 2-Stage Prepectoral Breast Reconstruction: Balancing Capsular Contracture and Complications https://news.medxy.ai/zh/optimize-dermal-matrix-size/Medxy AIzh2026-10-02T07:16:03-07:00优化无细胞真皮基质尺寸：降低胸肌前乳房重建包膜挛缩风险 https://news.medxy.ai/ja/adm-size-optimization/Medxy AIja2026-10-02T07:15:42-07:00前胸筋下乳房再建における被膜拘縮を抑えるADMサイズの最適化 https://news.medxy.ai/vi/optimize-dermal-matrix/Medxy AIvi2026-10-02T07:15:18-07:00Tối ưu hóa kích thước acellular dermal matrix để giảm co thắt bao xơ trong tái tạo vú trước cơ ngực https://news.medxy.ai/optimizing-acellular-dermal-matrix-size-to-minimize-capsular-contracture-in-prepectoral-breast-reconstruction/Medxy AIen2026-10-02T07:14:57-07:00Optimizing Acellular Dermal Matrix Size to Minimize Capsular Contracture in Prepectoral Breast Reconstruction https://news.medxy.ai/zh/migraine-surgery-timing/Medxy AIzh2026-10-02T07:14:17-07:00偏头痛触发点手术越早做，术后头痛改善越明显：来自台湾队列研究的启示 https://news.medxy.ai/ja/migraine-surgery-timing-2/Medxy AIja2026-10-02T07:13:55-07:00片頭痛手術は早いほど良い？ 台湾コホート研究が示す術後頭痛改善の鍵 https://news.medxy.ai/vi/79731-2/Medxy AIvi2026-10-02T07:13:34-07:00Phẫu thuật điều trị đau nửa đầu: Càng sớm càng tốt? Nghiên cứu đoàn hệ tại Đài Loan chỉ ra chìa khóa giúp cải thiện tình trạng đau đầu sau phẫu thuật https://news.medxy.ai/earlier-intervention-with-migraine-trigger-site-surgery-linked-to-improved-postoperative-headache-outcomes-insights-from-a-taiwanese-cohort-study/Medxy AIen2026-10-02T07:13:14-07:00Earlier Intervention with Migraine Trigger-Site Surgery Linked to Improved Postoperative Headache Outcomes: Insights from a Taiwanese Cohort Study